02591 銀諾醫藥－Ｂ
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
15/08/2025韓投夥伴（上海）創業投資管理有限責任公司1701(L)+41,731,556(L)41,731,556(L)9.93
15/08/2025Hong Kong Innogen Pharmaceutical Technology Co., Limited1701(L)+2,550,044(L)2,550,044(L)6.98
15/08/2025Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership)1701(L)+26,219,717(L)26,219,717(L)6.24
15/08/2025Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership)1701(L)+5,792,020(L)5,792,020(L)15.85
15/08/2025Guangzhou Nuosu Enterprise Management Partnership (Limited Partnership)1701(L)+23,168,082(L)23,168,082(L)5.51
15/08/2025Linden Investments Pte. Ltd.1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025Pavilion Capital GP Pte. Ltd.1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025PavCap Fund I1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025CICC Capital Management Co., Ltd. (中金资本运营有限公司)1701(L)+2,353,008(L)2,353,008(L)6.44
15/08/2025Fullerton Fund Investments Pte Ltd1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025景得(廣州)股權投資合夥企業(有限合夥)1701(L)+26,556,444(L)26,556,444(L)6.32
15/08/2025Temasek Holdings (Private) Limited1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025Palace Investments Pte. Ltd.1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025PavCap I Feeder No. 1 LP1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025Hong Kong Invengen Pharmaceutical Technology Co., Limited1701(L)+30,319,624(L)30,319,624(L)82.99
15/08/2025China International Capital Corporation Limited1701(L)+2,353,008(L)2,353,008(L)6.44
15/08/2025CICC Biomedical Fund L.P.1701(L)+2,353,008(L)2,353,008(L)6.44
15/08/2025Henan Zhongjin Huirong Private Equity Fund Management Co., Ltd.1701(L)+2,353,008(L)2,353,008(L)6.44
15/08/2025Shanghai Nuotang Biotechnology Co., Ltd.1701(L)+13,074,949(L)13,074,949(L)35.79
15/08/2025Shanghai Nuotang Biotechnology Co., Ltd.1701(L)+52,299,799(L)52,299,799(L)12.44
15/08/2025Pavilion Capital Holdings Pte. Ltd.1701(L)+25,344,931(L)25,344,931(L)6.03
15/08/2025Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership)1701(L)+6,554,929(L)6,554,929(L)17.94
15/08/2025KIP KIS SEA-CHINA Fund1701(L)+26,556,444(L)26,556,444(L)6.32
15/08/2025KOREA INVESTMENT HOLDINGS Co., Ltd.1701(L)+41,731,556(L)41,731,556(L)9.93
15/08/2025WANG QINGHUA1701(L)+30,319,624(L)30,319,624(L)82.99
15/08/2025WANG QINGHUA1701(L)+121,278,502(L)121,278,502(L)28.86
15/08/2025Hong Kong Invengen Pharmaceutical Technology Co., Limited1701(L)+121,278,502(L)121,278,502(L)28.56
15/08/2025KOREA INVESTMENT PARTNERS Co., Ltd.1701(L)+41,731,556(L)41,731,556(L)9.93
15/08/2025KOREA INVESTMENT & SECURITIES Co., Ltd1701(L)+26,556,444(L)26,556,444(L)6.32
 1  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.